17
total announcements
DIVISLAB.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 20 Oct 2026
Market Cap
₹2.41 L Cr
P/E (TTM)
82.5
P/E (Forward)
60.1
EPS (TTM)
₹110.21
52W Low
₹5,647.50
52W High
₹9,740.00
Dividend Yield
0.33%
Beta
0.23
Price / Book
14.4
Debt / Equity
0.0
Revenue (TTM)
₹11,230 Cr
Gross Margin
61.24%
Operating Margin
36.66%
Divi's Laboratories Limited
Divi's Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Divi's Laboratories Limited
Divi's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.
Divi's Laboratories Limited
Divi's Laboratories Limited has published a newspaper advertisement regarding the opening of a special window for transfer and dematerialisation of physical shares, as per SEBI Circular No. HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026.
Divi's Laboratories Limited
Divi's Laboratories Limited held its 36th Annual General Meeting on August 10, 2026, through Video Conferencing (VC) / Other Audio-Visual Means (OAVM). The meeting was attended by 150 members representing 12,42,61,211 shares. All resolutions set out in the Notice of 36th AGM were passed with requisite majority. The company has provided the facility for members to join the meeting through VC or OAVM and has also provided webcast facility to view the live proceedings of the AGM.
Divi's Laboratories Limited
Divi's Laboratories Limited has released the transcript of its Q1 FY27 earnings conference call, which was held on August 01, 2026. The call discussed the company's unaudited financial results for the quarter ended June 30, 2026, and provided an update on the company's business and operational developments.
Divi's Laboratories Limited
Divi's Laboratories Limited has informed the Exchange about the publication of unaudited financial results for the quarter ended June 30, 2026, in newspapers Financial Express and Andhra Prabha.
Divi's Laboratories Limited
Divi's Laboratories Limited has informed the Exchange about the link of recording of the Q1 FY 27 earnings conference call held on August 01, 2026, and the audio recording has been uploaded on their website.
Divi's Laboratories Limited
Divi's Laboratories Limited has informed the Exchange about change in Senior Management. The company has approved the appointment of Mr. B. Vara Prasad and Mr. J. Srinivasa Rao as Senior Management Personnel. The company has also approved the unaudited financial results for the quarter ended June 30, 2026, and the limited review report of the statutory auditors thereon.
Divi's Laboratories Limited
Divi's Laboratories Limited has submitted its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at ₹2974 crores and profit for the period at ₹891 crores. The company also approved the appointment of two senior management personnel.
Divi's Laboratories Limited
Divi's Laboratories Limited has informed the Exchange about the retirement of two senior management personnel, Mr. L. Ramesh Babu and Mr. D. Madhu Babu, effective July 31, 2026.
Divi's Laboratories Limited
Divi's Laboratories Limited has announced the schedule of earnings conference call for Q1 FY27, to be held on August 01, 2026, to discuss the company's unaudited financial results for the quarter ended June 30, 2026.
Divi's Laboratories Limited
Divi's Laboratories Limited has published a notice of its 36th Annual General Meeting, e-voting, and other information to shareholders in newspapers.
Divi's Laboratories Limited
Divi's Laboratories Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 10, 2026, where the company will consider and adopt the audited financial statements for the financial year ended March 31, 2026, and declare a dividend of `30/- per equity share of face value `2/- each.
Divi's Laboratories Limited
Divi's Laboratories Limited has informed the Exchange about a copy of newspaper publication regarding the notice of its 36th Annual General Meeting, record date for dividend, and other information.
Divi's Laboratories Limited
Divi's Laboratories Limited has submitted a certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2026, confirming compliance with the regulations.
Divi's Laboratories Limited
Divi's Laboratories Limited has submitted a disclosure under SEBI Takeover Regulations, detailing the shareholding pattern of its promoters and significant shareholders as of April 2026.
Divi's Laboratories Limited
Divi's Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The Trading Window for dealing in securities of the Company will remain closed from July 01, 2026, till 48 hours after the declaration of unaudited financial results of the Company for the quarter ended June 30, 2026.